Evidence map›Paper›PMID 19429439›Full record

ArticleThe Journal of steroid biochemistry and molecular biology2009

Estrogen-related receptor alpha induces the expression of vascular endothelial growth factor in breast cancer cells.

Rebecca A Stein, Stéphanie Gaillard, Donald P McDonnell

Open access · greenAbstract read
In one paragraph

Article in The Journal of steroid biochemistry and molecular biology, 2009. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 50 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
50citing papers in PubMed, 1 pooled it
3.1field-weighted citation impact, top 8% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

50 citing papers in PubMed, 1 synthesis or guideline pooled it, 92 citations in OpenAlex.

  1. Pooled it
  2. Structural Pharmacology of Estrogen-Related Receptors.ACS pharmacology & translational science · 2026
    Review
  3. Article
  4. Article
  5. Review
  6. Review
  7. Review
  8. Review
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Estrogen-related receptor α is involved in angiogenesis and skeletal muscle revascularization in hindlimb ischemia.FASEB journal : official publication of the Federation of American Societies for Experimental Biology · 2021
    Article
  15. Article
  16. Review
  17. Article
  18. Article
  19. Article
  20. The hallmarks of severe pulmonary arterial hypertension: the cancer hypothesis-ten years later.American journal of physiology. Lung cellular and molecular physiology · 2020
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 2 institutions in 1 country.

Rebecca A SteinDepartment of Pharmacology and Cancer Biology, Duke University Medical Center, Box 3813, Durham, NC 27710, United States.
Stéphanie Gaillard
Donald P McDonnell
Duke University Hospital · USJohns Hopkins University · US

Funding

Validation of the Estrogen Related Receptor as a therapeutic target in cancerR01DK074652 · NIDDK · DUKE UNIVERSITY · PI MCDONNELL, DONALD P · 2008 to 2012
$1.7M
NIDDK NIH HHS DK074652NIDDK NIH HHS R01 DK074652
6 · The paper itself

Abstract

Estrogen-related receptor alpha (ERRalpha) is an orphan member of the nuclear receptor family of transcription factors. In addition to its function as a metabolic regulator, ERRalpha has been implicated in the growth and progression of several malignancies. In the setting of breast cancer, not only is ERRalpha a putative negative prognostic factor, but we have recently found that knock-down of its expression retards tumor growth in a xenograft model of this disease. The specific aspects of ERRalpha function that are responsible for its actions in breast cancer, however, remain unclear. Using the coactivator PGC-1alpha as a protein ligand to regulate ERRalpha activity, we analyzed the effects of this receptor on gene expression in the ERalpha-positive MCF-7 cell line. This analysis led to the identification of a large number of potential ERRalpha target genes, many of which were subsequently validated in other breast cancer cell lines. Importantly, we demonstrate in this study that activation of ERRalpha in several different breast cancer cell lines leads to a significant increase in VEGF mRNA expression, an activity that translates into an increase in VEGF protein secretion. The induction of VEGF results from the interaction of ERRalpha with specific ERR-responsive elements within the VEGF promoter. These findings suggest that ERRalpha-dependent induction of VEGF may contribute to the overall negative phenotype observed in tumors in which ERRalpha is expressed and provide validation for its use as a therapeutic target in cancer.

Indexed as

AnimalsBreast NeoplasmsCell Line, TumorERRalpha Estrogen-Related ReceptorEstrogen Receptor alphaFemaleGene Expression Regulation, NeoplasticHeat-Shock ProteinsHumansPeroxisome Proliferator-Activated Receptor Gamma Coactivator 1-alphaPromoter Regions, GeneticReceptors, EstrogenTranscription FactorsVascular Endothelial Growth Factor AERRalpha Estrogen-Related ReceptorEstrogen Receptor alphaHeat-Shock ProteinsPeroxisome Proliferator-Activated Receptor Gamma Coactivator 1-alphaPPARGC1A protein, humanReceptors, EstrogenTranscription FactorsVascular Endothelial Growth Factor A

Identifiers

PMID19429439
PMCPMC2680788
OpenAlexW2039668230

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.